Schedule 13G ownership disclosure

PHIO PHARMACEUTICALS CORP

Common Stock, par value $0.0001 per share · CUSIP: 71880W501

Event date: 2024-12-19

Filing-level shares
514,965.00
Percent of class
9.9%
  • Orca Capital AG

    Shares: 514,965.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-25-003376
Form type
SCHEDULE 13G
Filer
Orca Capital AG
CIK
CIK 2052389
Filed
Jan 23, 2025
Reporting period
Dec 19, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub